PharmEasy closes $350 million in pre-IPO round, valuation jumps to $5.6 billion

Online pharmacy PharmEasy has closed a funding round worth nearly $350 million ahead of filing its draft red herring prospectus (DRHP) before an Initial Public Offering (IPO), according to regulatory documents sourced by ET and people briefed on the matter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aJRlwq
via IFTTT